Skip to main content

Table 1 Main characteristics of studies on Lin28 (Lin28A) and cancer prognosis

From: Prognostic value of Lin28A and Lin28B in various human malignancies: a systematic review and meta-analysis

First author

Case nationality

Region

Age, years

Included number

Malignant disease

Detected sample

Analysis method

Survival analysis

Hsu, 2015

Chinese Taiwan

Asia

53.80mean

140

EOC

Tissue

IHC

PFS

Tu, 2015

USA

North America

NA

595

CRC

Tissue

IHC

OS

Faria, 2015

Germany/Brazil

Europe

< 45.80

124 (DFS)/188 (OS)

ACC

Tissue

IHC

OS/DFS

Qin, 2014

China

Asia

50.00median

90

Glioma

Tissue

IHC

OS/PFS

Wang, 2014

China

Asia

59.60mean

298

GC

Tissue

IHC

OS/DFS

Liu, 2013

China

Asia

46.00median

86

Breast cancer

Tissue

IHC

OS

Xu, 2013

China

Asia

56.00median

229

GC

Tissue

IHC

OS

Yin, 2013

China

Asia

49.00median

57

HCC

Tissue

qRT-PCR

OS/RFS

Ma, 2013

USA

North America

60.78mean

343

EOC

Tissue

AQUA

OS/PFS

Wu, 2013

China

Asia

60.00mean

72

OSCC

Tissue

IHC

OS/DFS

Feng, 2012

USA

North America

50.00median

569

Breast cancer

Tissue

AQUA

OS

Hamano, 2012

Japan

Asia

65.00mean

161

OC

Tissue

IHC

OS/DFS

Qiu, 2012

China

Asia

50.00median

53

HCC

Tissue

PCR

OS/RFS

Rodini, 2012

Brazil

South America

NA

37

Medulloblastoma

Tissue

qRT-PCR

OS

Korshunov, 2012

Germany

Europe

< 18.00

816

ETMR

Tissue

IHC

OS

Kim, 2011

South Korea

Asia

48.00median

38

NPC

Tissue

IHC

OS/PFS

  1. EOC epithelial ovarian cancer, CRC colorectal cancer, ACC adrenocortical cancer, GC gastric cancer, HCC hepatocellular carcinoma, OSCC oral squamous cell carcinoma, ETMR embryonal tumor with multilayered rosettes, OC oesophagus cancer, NPC nasopharyngeal carcinoma, PFS progression-free survival, OS overall survival, DFS disease-free survival, RFS recurrence-free survival, IHC immunohistochemistry, qRT-PCR quantitative real-time PCR, AQUA automated quantitative analysis